Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceuticals targeting cancer pathways such as JAK and EGFR. Its structure enables selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in research and development of targeted therapies for leukemia, solid tumors, and inflammatory diseases. Also utilized in the preparation of radiolabeled compounds for diagnostic imaging and metabolic studies.